CapsoVision (CV) Non-Current Assets (2024 - 2026)
CapsoVision (CV) posted Non-Current Assets of $1.5 million for Q4 2025, down 7.49% sequentially from $1.6 million in Q3 2025, and down 23.57% YoY from $2.0 million in Q4 2024.
CapsoVision (CV) Non-Current Assets (2024 - 2026) Analysis & Trends
CapsoVision has reported Non-Current Assets for 2 years, with the latest figure at $1.5 million in Q4 2025.
- Quarterly Non-Current Assets fell 23.57% year-over-year to $1.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.8 million (changed N/A YoY) and the FY2025 annual result came in at $1.5 million, down 23.57% from the prior year.
- Non-Current Assets retreated to $1.5 million in Q4 2025 per CV's latest filing, from $1.6 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $2.0 million in Q4 2024 and troughed at $1.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | CapsoVision | 295.13 Mn | 286.05 Mn | 1.87 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.29 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 1.62 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Dec 31, 2024 | 1.96 Mn |